Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
VRAXVirax Biolabs Group Ltd
| Figure | VRAXVirax Biolabs Group LtdFY2025 · Mar |
|---|---|
| Revenue | $6.33K |
| Revenue, yoy | −96.0% |
| Net income | $6.06M |
| Net income, yoy | +10.0% |
| Net margin | -95,739.2% |
| Free cash flow | $5.17M |
| FCF margin | -81,621.6% |
| EPS, diluted | $1.62 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed